切换至 "中华医学电子期刊资源库"

中华腔镜外科杂志(电子版) ›› 2021, Vol. 14 ›› Issue (04): 245 -247. doi: 10.3877/cma.j.issn.1674-6899.2021.04.013

病例报告 上一篇    下一篇

全脏器反位患者机器人辅助下宫颈癌根治术一例
苏英杰 1, 窦磊 1, 田东立 1, 芦恩婷 1, 张颐 1 , ( )   
  1. 1. 110000 沈阳,中国医科大学附属第一医院妇科
  • 收稿日期:2021-07-04 出版日期:2021-10-08
  • 通信作者: 张颐
  • 基金资助:
    辽宁省中央引导地方科技发展专项(2019JH6/10400006); 国家重点研发计划项目(2018YFC1311600)

The situs inversus totalis (SIT) patient undergoing robot assisted radical hysterectomy surgery successfully: a case report

Yingjie Su 1, Lei Dou 1, Dongli Tian 1, Enting Lu 1, Yi Zhang 1 , ( )   

  1. 1. Department of Gynecology, the First Affiliated Hospital of China Medical University, Shenyang 110000, China
  • Received:2021-07-04 Published:2021-10-08
  • Corresponding author: Yi Zhang
目的

探讨全脏器反位(situs inversus totalis,SIT)患者行机器人辅助下宫颈癌根治术的安全性和可行性。

方法

回顾性分析2019年1月中国医科大学附属第一医院妇科1例SIT合并宫颈癌患者的临床资料。

结果

患者顺利完成手术,总手术时间7 h,其中术者操作时间6.5 h;术中出血量约50 ml,术后病理为宫颈鳞状细胞癌。

结论

SIT合并宫颈癌患者行达芬奇机器人辅助下宫颈癌根治术具有一定的安全性和有效性,同时具有创伤小、疼痛轻、恢复快、切口美观等优点。

Objective

To investigate the safety and feasibility of robot-assisted radical hysterectomy in patients with situs inversus totalis.

Methods

A retrospective analysis of the clinical information of a patient with situs inversus totalis combined with cervical cancer in the Department of Gynecology, First Affiliated Hospital of China Medical University in Jan. 2019.

Results

The patient successfully completed the operation. The total operation time was 7 hours, the operation time of the surgeon was 6.5 hours, the intraoperative blood loss was about 50 ml, and the postoperative pathology was cervical squamous cell carcinoma.

Conclusions

Da Vinci robot-assisted radical hysterectomy for patients with situs inversus totalis and cervical cancer has a certain degree of safety and effectiveness. At the same time, it has the advantages of small trauma, less pain, quick recovery, and beautiful incision.

图1 全脏器反位合并宫颈癌患者的术前肺CT(A、B)
图2 全脏器反位合并宫颈癌患者Trocar位置
图3 广泛子宫全切除、双侧卵巢输卵管切除、盆腔淋巴结清扫术完毕(A~D)
1
Casey B. Genetics of human situs abnormalities[J]. Am J Med Genet, 2001, 101(4): 356-358.
2
Chib P, Grover DN, Shahi BN. Unusual occurrence of dextrocardia with situs inversus in succeeding generations of a family[J]. J Med Genet, 197714(1): 30-32.
3
赵孟玲,郭瑞霞.机器人辅助腹腔镜宫颈癌转移淋巴结切除经验及思考[J/CD]. 中华腔镜外科杂志(电子版)201912(4):222-225.
4
Boskovski MT, Yuan S, Pedersen NB, et al. The heterotaxy gene galnt11 glycosylates notch to orchestrate cilia type and laterality[J]. Nature, 2013, 504(7480): 456-459.
5
Iusco DR, Sacco S, Ismail I, et al. Three-trocar laparoscopic cholecystectomy in patient with situs viscerum inversus totalis: case report and review of the literature[J]. G Chir, 2012, 33(1): 10-13.
6
Maclean K, Dunwoodie SL. Breaking symmetry: a clinical overview of left-right patterning[J]. Clin Genet, 2004, 65(6): 441-457.
7
Koh WJ, Abu-Rustum NR, Bean S, et al. Cervical cancer, version 3.2019, nccn clinical practice guidelines in oncology[J]. J Natl Compr Canc Netw, 2019, 17(1): 64-84.
8
Miller JW, Hanson V, Johnson GD, et al. From cancer screening to treatment: service delivery and referral in the national breast and cervical cancer early detection program[J]. Cancer, 2014, 120(16): 2549-2556.
9
Kim K, Zang R, Choi SC, et al. Current status of gynecological cancer in china[J]. J Gynecol Oncol, 2009, 20(2): 72-76.
10
Puntambekar SP, Palep RJ, Puntambekar SS, et al. Laparoscopic total radical hysterectomy by the pune technique: our experience of 248 cases[J]. J Minim Invasive Gynecol, 2007, 14(6): 682-689.
11
Chen Y, Xu H, Li Y, et al. The outcome of laparoscopic radical hysterectomy and lymphadenectomy for cervical cancer: a prospective analysis of 295 patients[J]. Ann Surg Oncol, 2008, 15(10): 2847-2855.
12
Nam JH, Park JY, Kim DY, et al. Laparoscopic versus open radical hysterectomy in early-stage cervical cancer: long-term survival outcomes in a matched cohort study[J]. Ann Oncol, 2012, 23(4): 903-911.
13
Sert BM, Boggess JF, Ahmad S, et al. Robot-assisted versus open radical hysterectomy: a multi-institutional experience for early-stage cervical cancer[J]. Eur J Surg Oncol, 2016, 42(4): 513-522.
14
Mendivil AA, Rettenmaier MA, Abaid LN, et al. Survival rate comparisons amongst cervical cancer patients treated with an open, robotic-assisted or laparoscopic radical hysterectomy: a five year experience[J]. Surg Oncol, 2016, 25(1): 66-71.
15
Park DA, Yun JE, Kim SW, et al. Surgical and clinical safety and effectiveness of robot-assisted laparoscopic hysterectomy compared to conventional laparoscopy and laparotomy for cervical cancer: a systematic review and meta-analysis[J]. Eur J Surg Oncol, 2017, 43(6): 994-1002.
16
Ramirez PT, Frumovitz M, Pareja R, et al. Minimally invasive versus abdominal radical hysterectomy for cervical cancer[J]. N Engl J Med, 2018, 379(20): 1895-1904.
17
Melamed A, Margul DJ, Chen L, et al. Survival after minimally invasive radical hysterectomy for early-stage cervical cancer[J]. N Engl J Med, 2018, 379(20): 1905-1914.
18
Abu-Rustum NR, Yashar CM, Bean S, et al. Nccn guidelines insights: cervical cancer, version 1.2020[J]. J Natl Compr Canc Netw, 2020, 18(6): 660-666.
[1] 王一然, 王平. 《巴西肿瘤外科协会盆腔廓清术治疗宫颈癌指南》解读[J]. 中华妇幼临床医学杂志(电子版), 2021, 17(02): 142-151.
[2] 郑晓霞, 李大鹏. 中性粒细胞计数与淋巴细胞计数比值对局部晚期宫颈癌患者新辅助化疗疗效的预测价值[J]. 中华妇幼临床医学杂志(电子版), 2020, 16(05): 558-566.
[3] 吴迪, 闫志风, 佘宇佳, 张妮娜, 孟元光. 达芬奇机器人系统在超重肥胖妇科恶性肿瘤患者治疗中的优势分析[J]. 中华腔镜外科杂志(电子版), 2021, 14(04): 206-210.
[4] 胡剑翀, 邹浩, 朱呈瞻, 吴泽华, 宋孟锜, 马凯, 韩冰, 孙传东. 达芬奇机器人与开腹胰十二指肠切除术临床疗效比较[J]. 中华腔镜外科杂志(电子版), 2021, 14(02): 75-80.
[5] 潘玉英, 孙力, 王桂香, 李华, 杨萌. 腹腔镜手术治疗宫颈癌复发一例[J]. 中华腔镜外科杂志(电子版), 2021, 14(01): 53-57.
[6] 马丽芳, 邹冬玲, 周琦. 达芬奇机器人辅助腹主动脉旁淋巴结切除术在宫颈癌分期术中的应用[J]. 中华腔镜外科杂志(电子版), 2020, 13(05): 278-282.
[7] 郭静, 齐卫红. circ_0000218通过靶向吸附miR-1182对宫颈癌HeLa细胞增殖、迁移和侵袭的影响[J]. 中华细胞与干细胞杂志(电子版), 2021, 11(02): 113-119.
[8] 廖欣, 顾一平, 廖薇. 低强度超声对HeLa肿瘤细胞凋亡的诱导作用及其机制[J]. 中华细胞与干细胞杂志(电子版), 2020, 10(05): 277-282.
[9] 首泉, 王茜, 谭志远. miR-98-5p靶向PYGO2基因对宫颈癌细胞增殖、迁移和侵袭的影响及其作用机制研究[J]. 中华细胞与干细胞杂志(电子版), 2020, 10(03): 138-145.
[10] 吴宏宇, 汤庆超, 金英虎, 胡志乔, 王贵玉. 机器人腹部无辅助切口经直肠拖出标本的高位直肠癌根治术(NOSES-IV式)(附视频)[J]. 中华结直肠疾病电子杂志, 2020, 09(06): 645-648.
[11] 吴宏宇, 黄睿, 胡汉卿, 管子龙, 王贵玉. 机器人腹部无辅助切口经直肠拉出切除标本的中位直肠癌根治术(NOSES-Ⅱ式)(附视频)[J]. 中华结直肠疾病电子杂志, 2020, 09(04): 429-432.
[12] 唐和春, 刘东宁, 朱伟权, 罗瑞, 何鹏辉, 李太原. 腹部无辅助切口经肛门外翻切除标本的机器人低位直肠癌根治术(NOSES Ⅰ式)一例报道[J]. 中华结直肠疾病电子杂志, 2020, 09(03): 296-298.
[13] 朱伟权, 刘东宁, 唐和春, 罗瑞, 何鹏辉, 温祥琼, 唐城, 李太原. 腹部无辅助切口经肛门取标本的机器人高位直肠癌根治术一例报道(CRC-NOSES Ⅳ式)[J]. 中华结直肠疾病电子杂志, 2020, 09(02): 201-203.
[14] 刘萍, 潘九林. 补救性放化疗对宫颈癌术后盆腔复发和未控患者的治疗价值[J]. 中华临床医师杂志(电子版), 2020, 14(04): 267-271.
[15] 贾卓奇, 周维茹, 陈南征, 贺海奇, 李硕, 马磊, 张勇, 张广健, 付军科. 达芬奇机器人食管裂孔疝修补术临床疗效分析[J]. 中华胃食管反流病电子杂志, 2020, 07(02): 71-76.
阅读次数
全文


摘要